Cystatin C has shown promise as a mid-term marker of renal dysfunction as evidenced by Turan et al. [14] in a well-controlled RCT, demonstrating its superiority over creatinine in detecting renal dysfunction at one and 30 days post-ESWL. The gene discussed is CST3; the disease is Abnormal renal physiology.